first generic glp 1 FDA approves GLP-1 diabetes drug Diabetes patients now have access

Published February 8, 2021 - More info Glucagon-like peptide-1 (GLP-1) is an incretin hormone that potentiates glucose-stimulated insulin secretion

Treatment plans may include medication when clinically appropriate, with monthly physician follow-ups and a guided maintenance phase built in from the start

These metabolites are biologically active, can reduce intravascular oxidative stress, inhibit hepatocyte gluconeogenesis and oxidative stress, increase cardiomyocyte activity, promote vasodilation, protect the cardiovascular system, improve cardiac function, thereby directly or indirectly protecting the cardiovascular system ( 4.3 Nervous system disorder Recently, a protective effect of the GLP-1/GLP-1R axis on ischemic brain injury has been emphasized

It should be noted that the cerebral cortex and the cerebellum interestingly lack the expression of the GLP-1R in rat models [51]

Great came fast work very well Love the energy